<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on August 28, 2026 at 11:31 pm by All in One SEO v5.0.0.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://www.shifamed.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Shifamed</title>
		<link><![CDATA[https://www.shifamed.com]]></link>
		<description><![CDATA[Shifamed]]></description>
		<lastBuildDate><![CDATA[Thu, 23 Jul 2026 18:16:17 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://www.shifamed.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://www.shifamed.com/portfolio/tioga-medical/]]></guid>
			<link><![CDATA[https://www.shifamed.com/portfolio/tioga-medical/]]></link>
			<title>Tioga Cardiovascular</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:16:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/portfolio/supira-medical/]]></guid>
			<link><![CDATA[https://www.shifamed.com/portfolio/supira-medical/]]></link>
			<title>Supira Medical</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:15:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/portfolio/myra-vision/]]></guid>
			<link><![CDATA[https://www.shifamed.com/portfolio/myra-vision/]]></link>
			<title>Myra Vision</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:13:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/portfolio/laza-medical/]]></guid>
			<link><![CDATA[https://www.shifamed.com/portfolio/laza-medical/]]></link>
			<title>Laza Medical</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:13:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/portfolio/enlil/]]></guid>
			<link><![CDATA[https://www.shifamed.com/portfolio/enlil/]]></link>
			<title>Enlil</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:12:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/portfolio/atia-vision/]]></guid>
			<link><![CDATA[https://www.shifamed.com/portfolio/atia-vision/]]></link>
			<title>Atia Vision</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:12:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/portfolio/akura-medical/]]></guid>
			<link><![CDATA[https://www.shifamed.com/portfolio/akura-medical/]]></link>
			<title>Akura Medical</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:12:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/portfolio/adona-medical/]]></guid>
			<link><![CDATA[https://www.shifamed.com/portfolio/adona-medical/]]></link>
			<title>Adona Medical</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:10:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/careers/]]></guid>
			<link><![CDATA[https://www.shifamed.com/careers/]]></link>
			<title>Careers</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:07:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/shifamed-overview-video/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/shifamed-overview-video/]]></link>
			<title>Intro to Shifamed, a medical technology innovation hub located in the heart of Silicon Valley</title>
			<pubDate><![CDATA[Wed, 09 Apr 2025 19:14:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/]]></guid>
			<link><![CDATA[https://www.shifamed.com/]]></link>
			<title>HOME</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:05:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/people/]]></guid>
			<link><![CDATA[https://www.shifamed.com/people/]]></link>
			<title>People</title>
			<pubDate><![CDATA[Thu, 23 Jul 2026 18:19:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/myra-vision-secures-fda-approval-to-initiate-us-ide-study-in-glaucoma/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/myra-vision-secures-fda-approval-to-initiate-us-ide-study-in-glaucoma/]]></link>
			<title>Myra Vision Secures FDA Approval to Initiate US IDE Study in Glaucoma</title>
			<pubDate><![CDATA[Tue, 12 Aug 2025 22:33:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/first-patient-treated-in-myra-visions-u-s-adapt-clinical-study-for-glaucoma/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/first-patient-treated-in-myra-visions-u-s-adapt-clinical-study-for-glaucoma/]]></link>
			<title>First Patient Treated in Myra Vision’s U.S. ADAPT Clinical Study for Glaucoma</title>
			<pubDate><![CDATA[Thu, 21 May 2026 18:27:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/supira-medical-ceo-interview-with-joe-mullings-at-tct-2024/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/supira-medical-ceo-interview-with-joe-mullings-at-tct-2024/]]></link>
			<title>Supira Medical CEO Interview with Joe Mullings at TCT 2024</title>
			<pubDate><![CDATA[Wed, 09 Apr 2025 19:14:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/tioga-cardiovascular-ceo-mike-dineen-interview-with-joe-mullings-at-tct-2024/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/tioga-cardiovascular-ceo-mike-dineen-interview-with-joe-mullings-at-tct-2024/]]></link>
			<title>Tioga Cardiovascular CEO Mike Dineen Interview with Joe Mullings at TCT 2024</title>
			<pubDate><![CDATA[Wed, 09 Apr 2025 19:14:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/shifamed-manufacturing-innovation-and-excellence/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/shifamed-manufacturing-innovation-and-excellence/]]></link>
			<title>Shifamed Manufacturing Innovation and Excellence</title>
			<pubDate><![CDATA[Wed, 09 Apr 2025 19:14:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/adona-medical-completes-enrollment-in-first-in-human-trial-for-novel-interatrial-shunt-for-patients-with-heart-failure/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/adona-medical-completes-enrollment-in-first-in-human-trial-for-novel-interatrial-shunt-for-patients-with-heart-failure/]]></link>
			<title>Adona Medical Completes Enrollment in First-in-human Trial for Novel Interatrial Shunt for Patients With Heart Failure</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 21:31:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/creating-an-ecosystem-for-innovation-in-medtech/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/creating-an-ecosystem-for-innovation-in-medtech/]]></link>
			<title>Creating an ecosystem for innovation in medtech</title>
			<pubDate><![CDATA[Wed, 09 Apr 2025 19:15:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/supira-medical-announces-fda-approval-for-support-ii-pivotal-trial-advances-in-cardiogenic-shock-and-appointment-of-d-keith-grossman-to-board-of-directors/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/supira-medical-announces-fda-approval-for-support-ii-pivotal-trial-advances-in-cardiogenic-shock-and-appointment-of-d-keith-grossman-to-board-of-directors/]]></link>
			<title>Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 15:20:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/fda-grants-atia-vision-approval-to-begin-us-clinical-trial-of-omnivu-lens-system-in-patients-with-cataracts/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/fda-grants-atia-vision-approval-to-begin-us-clinical-trial-of-omnivu-lens-system-in-patients-with-cataracts/]]></link>
			<title>FDA Grants Atia Vision Approval to begin US Clinical Trial of OmniVu™ Lens System in Patients with Cataracts</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 21:32:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/about/]]></guid>
			<link><![CDATA[https://www.shifamed.com/about/]]></link>
			<title>About</title>
			<pubDate><![CDATA[Wed, 08 Oct 2025 18:19:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/laza-medical-achieves-first-in-human-use-of-real-time-ai-heart-model-for-ultrasound-guided-cardiac-procedures/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/laza-medical-achieves-first-in-human-use-of-real-time-ai-heart-model-for-ultrasound-guided-cardiac-procedures/]]></link>
			<title>Laza Medical Achieves First-in-Human Use of Real-Time AI Heart Model for Ultrasound-Guided Cardiac Procedures</title>
			<pubDate><![CDATA[Wed, 03 Sep 2025 14:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/myra-vision-announces-positive-initial-outcomes-from-its-feasibility-study-at-the-2025-american-glaucoma-society-meeting/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/myra-vision-announces-positive-initial-outcomes-from-its-feasibility-study-at-the-2025-american-glaucoma-society-meeting/]]></link>
			<title>Myra Vision Announces Positive Initial Outcomes from its Feasibility Study at the 2025 American Glaucoma Society Meeting</title>
			<pubDate><![CDATA[Tue, 12 Aug 2025 22:34:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/laza-medical-inc-a-shifamed-portfolio-company-closes-36m-in-series-a-financing/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/laza-medical-inc-a-shifamed-portfolio-company-closes-36m-in-series-a-financing/]]></link>
			<title>Laza Medical, Inc., a Shifamed Portfolio Company, Closes $36m in Series A Financing</title>
			<pubDate><![CDATA[Tue, 02 Sep 2025 22:44:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/laza-medical-gm-pablo-garcia-interview-with-joe-mullings-at-tct-2024/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/laza-medical-gm-pablo-garcia-interview-with-joe-mullings-at-tct-2024/]]></link>
			<title>Laza Medical GM Pablo Garcia Interview with Joe Mullings at TCT 2024</title>
			<pubDate><![CDATA[Thu, 07 Aug 2025 16:05:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/envisioning-the-future-with-laza-medical/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/envisioning-the-future-with-laza-medical/]]></link>
			<title>Envisioning the Future with Laza Medical</title>
			<pubDate><![CDATA[Wed, 30 Jul 2025 23:09:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/first-patient-enrolled-in-akura-medicals-us-pivotal-trial-for-pulmonary-embolism/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/first-patient-enrolled-in-akura-medicals-us-pivotal-trial-for-pulmonary-embolism/]]></link>
			<title>First patient enrolled in Akura Medical&#8217;s US pivotal trial for pulmonary embolism</title>
			<pubDate><![CDATA[Tue, 20 May 2025 18:37:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/supira-medical-secures-120m-oversubscribed-series-e-financing-and-completes-enrollment-of-support-i-early-feasibility-study-in-the-united-states/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/supira-medical-secures-120m-oversubscribed-series-e-financing-and-completes-enrollment-of-support-i-early-feasibility-study-in-the-united-states/]]></link>
			<title>Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States</title>
			<pubDate><![CDATA[Wed, 26 Mar 2025 15:16:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/shifamed-innovation-video/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/shifamed-innovation-video/]]></link>
			<title>An inside look at Shifamed&#8217;s innovation process &#8212; from ideation to solution</title>
			<pubDate><![CDATA[Wed, 09 Apr 2025 19:14:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/strategic-investments-structured-transactions-and-creative-deals/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/strategic-investments-structured-transactions-and-creative-deals/]]></link>
			<title>Strategic Investments, Structured Transactions and Creative Deals</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 21:31:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/akura-medical-a-shifamed-portfolio-company-closes-53-million-in-series-c-financing/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/akura-medical-a-shifamed-portfolio-company-closes-53-million-in-series-c-financing/]]></link>
			<title>Akura Medical, a Shifamed Portfolio Company, Closes $53 Million in Series C Financing</title>
			<pubDate><![CDATA[Mon, 01 Dec 2025 14:06:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/supira-medical-initiates-u-s-early-feasibility-study-efs-for-high-risk-pci/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/supira-medical-initiates-u-s-early-feasibility-study-efs-for-high-risk-pci/]]></link>
			<title>Supira Medical Initiates U.S. Early Feasibility Study (EFS) for High-Risk PCI</title>
			<pubDate><![CDATA[Thu, 10 Apr 2025 18:22:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/adona-medical-initiates-first-in-human-study-with-its-novel-interatrial-shunt-for-patients-with-heart-failure/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/adona-medical-initiates-first-in-human-study-with-its-novel-interatrial-shunt-for-patients-with-heart-failure/]]></link>
			<title>Adona Medical Initiates First-in-Human Study With Its Novel Interatrial Shunt for Patients With Heart Failure</title>
			<pubDate><![CDATA[Wed, 04 Dec 2024 22:57:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/a-data-driven-approach-to-heart-failure-management/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/a-data-driven-approach-to-heart-failure-management/]]></link>
			<title>A Data-Driven Approach to Heart Failure Management</title>
			<pubDate><![CDATA[Mon, 24 Mar 2025 16:20:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/akura-medical-secures-fda-approval-for-us-pivotal-trial-in-pulmonary-embolism/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/akura-medical-secures-fda-approval-for-us-pivotal-trial-in-pulmonary-embolism/]]></link>
			<title>Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism</title>
			<pubDate><![CDATA[Thu, 13 Feb 2025 20:42:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/article/great-aspirations-new-mechanical-approaches-to-treating-pulmonary-embolism/]]></guid>
			<link><![CDATA[https://www.shifamed.com/article/great-aspirations-new-mechanical-approaches-to-treating-pulmonary-embolism/]]></link>
			<title>Great Aspirations: New Mechanical Approaches to Treating Pulmonary Embolism</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 22:38:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/article/tmvr-company-tioga-cardiovascular-offers-next-generation-ease-of-delivery/]]></guid>
			<link><![CDATA[https://www.shifamed.com/article/tmvr-company-tioga-cardiovascular-offers-next-generation-ease-of-delivery/]]></link>
			<title>TMVR Company Tioga Cardiovascular Offers Next-Generation Ease of Delivery</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 22:33:14 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/article/smaller-faster-better-new-developments-in-pvad/]]></guid>
			<link><![CDATA[https://www.shifamed.com/article/smaller-faster-better-new-developments-in-pvad/]]></link>
			<title>Smaller, Faster, Better: New Developments in pVAD</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 22:27:39 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/podcast/how-nitin-salunkes-different-mindset-helped-him-shift-career-from-engineer-to-ceo-of-supira-medical/]]></guid>
			<link><![CDATA[https://www.shifamed.com/podcast/how-nitin-salunkes-different-mindset-helped-him-shift-career-from-engineer-to-ceo-of-supira-medical/]]></link>
			<title>How Nitin Salunke’s different mindset helped him shift career from engineer to CEO of Supira Medical</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 21:40:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/podcast/identifying-and-mitigating-key-risk-factors-in-medtech-startups/]]></guid>
			<link><![CDATA[https://www.shifamed.com/podcast/identifying-and-mitigating-key-risk-factors-in-medtech-startups/]]></link>
			<title>Identifying and Mitigating Key Risk Factors in Medtech Startups</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 21:31:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/podcast/amr-salahieh-on-the-keys-to-successful-entrepreneurship/]]></guid>
			<link><![CDATA[https://www.shifamed.com/podcast/amr-salahieh-on-the-keys-to-successful-entrepreneurship/]]></link>
			<title>Amr Salahieh on the Keys to Successful Entrepreneurship</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 19:40:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/news/]]></guid>
			<link><![CDATA[https://www.shifamed.com/news/]]></link>
			<title>News</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 18:59:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/https-www-prnewswire-com-news-releases-atia-vision-a-shifamed-portfolio-company-closes-10m-in-series-c-financing-300762150-html/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/https-www-prnewswire-com-news-releases-atia-vision-a-shifamed-portfolio-company-closes-10m-in-series-c-financing-300762150-html/]]></link>
			<title>Atia Vision Closes on Last Tranche of $10M in Series C Financing</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 18:13:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/nuvera-medical-raises-new-financing/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/nuvera-medical-raises-new-financing/]]></link>
			<title>NuVera Medical Raises New Financing</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 18:13:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/joe-mullings-interviews-amr-salahieh-founder-ceo-of-shifamed/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/joe-mullings-interviews-amr-salahieh-founder-ceo-of-shifamed/]]></link>
			<title>How Shifamed&#8217;s centralized model and state-of-the-art campus create the ideal environment for innovation</title>
			<pubDate><![CDATA[Mon, 24 Mar 2025 16:16:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/podcast/shifamed-start-up-tioga-cardiovascular-looking-to-redefine-mitral-and-tricuspid-valve-replacement/]]></guid>
			<link><![CDATA[https://www.shifamed.com/podcast/shifamed-start-up-tioga-cardiovascular-looking-to-redefine-mitral-and-tricuspid-valve-replacement/]]></link>
			<title>Shifamed Start-Up Tioga Cardiovascular looking to redefine mitral and tricuspid valve replacement</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 21:47:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/tioga-medical-a-shifamed-portfolio-company-closes-15m-in-series-a-financing/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/tioga-medical-a-shifamed-portfolio-company-closes-15m-in-series-a-financing/]]></link>
			<title>Tioga Medical, A Shifamed Portfolio Company, Closes $15M In Series A Financing</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 18:12:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/press-releases/atia-vision-announces-upcoming-presentations-highlighting-modular-presbyopia-correcting-intraocular-lens-technology/]]></guid>
			<link><![CDATA[https://www.shifamed.com/press-releases/atia-vision-announces-upcoming-presentations-highlighting-modular-presbyopia-correcting-intraocular-lens-technology/]]></link>
			<title>Atia Vision Announces Upcoming Presentations Highlighting Modular Presbyopia-Correcting Intraocular Lens Technology</title>
			<pubDate><![CDATA[Mon, 25 Nov 2024 18:12:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.shifamed.com/video/starfish-presentation/]]></guid>
			<link><![CDATA[https://www.shifamed.com/video/starfish-presentation/]]></link>
			<title>A MedTech Entrepreneur&#8217;s Journey with Shifamed CEO Amr Salahieh</title>
			<pubDate><![CDATA[Mon, 24 Mar 2025 16:28:12 +0000]]></pubDate>
		</item>
				</channel>
</rss>
